Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

STRATA Skin Sciences (SSKN) Receivables - Net (2016 - 2025)

Historic Receivables - Net for STRATA Skin Sciences (SSKN) over the last 14 years, with Q3 2025 value amounting to $3.5 million.

  • STRATA Skin Sciences' Receivables - Net changed N/A to $3.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.5 million, marking a year-over-year change of. This contributed to the annual value of $5.3 million for FY2024, which is 1831.08% up from last year.
  • According to the latest figures from Q3 2025, STRATA Skin Sciences' Receivables - Net is $3.5 million.
  • STRATA Skin Sciences' Receivables - Net's 5-year high stood at $5.3 million during Q4 2024, with a 5-year trough of $2.9 million in Q1 2021.
  • Over the past 5 years, STRATA Skin Sciences' median Receivables - Net value was $3.8 million (recorded in 2022), while the average stood at $3.9 million.
  • Data for STRATA Skin Sciences' Receivables - Net shows a peak YoY increase of 10969.88% (in 2021) and a maximum YoY decrease of 1106.61% (in 2021) over the last 5 years.
  • Quarter analysis of 5 years shows STRATA Skin Sciences' Receivables - Net stood at $3.4 million in 2021, then soared by 30.24% to $4.5 million in 2022, then fell by 0.69% to $4.4 million in 2023, then rose by 18.31% to $5.3 million in 2024, then crashed by 33.3% to $3.5 million in 2025.
  • Its last three reported values are $3.5 million in Q3 2025, $4.0 million for Q2 2025, and $5.0 million during Q1 2025.